top of page



Richard Chin, MD

Managing Director

Richard was previously Founder and CEO of KindredBio (NASDAQ:KIN), a biotechnology company developing medicines for pets, which was acquired by Elanco; Head of Clinical Research for the Biotherapeutics Unit at Genentech; Senior Vice President of Global Development at Elan; CEO of Oxigene (NASDAQ:OXGN); and CEO of OneWorld Health, a Gates Foundation-funded nonprofit making medicines for impoverished patients in developing countries. Drugs Richard developed have current aggregate sales of well over $10 billion per year. Richard is a Harvard-trained physician, an Oxford-trained lawyer, and a Rhodes Scholar. He has been named by BusinessWeek as one of 99 youngest public company CEOs in the United States.


Tomas Mandia


Tomas has extensive media industry knowledge, having worked at global media agencies (OMD; NASDAQ:OMC), global publishers (BBC World News), global ad-tech vendors (SoPost) and Middle Eastern unicorns (Bayut-Dubizzle). Tomas holds a BA in Creative Advertising from University of the Arts London and an MBA.

Screen Shot 2022-12-12 at 10_edited.jpg

Stephen Sundlof, DVM, PhD


Steve is a veterinarian and Ph.D toxicologist who served as the Director of the Center for Veterinary Medicine at the FDA from 1994 to 2008. He also served as the Director of Center for Food Safety and Applied Nutrition at the FDA from 2008 to 2010. Prior to that, he was on the faculty of the University of Florida’s College of Veterinary Medicine. In 1994.

bottom of page